Differential effect of ebselen on compound 48/80- and anti-IgE-induced histamine release from rat peritoneal mast cells

Biochemical Pharmacology

Volumn 56, Issue 11, 1998, Pages 1525-1528

  Tchoumkeu Nzouessa, Guizot C ^a   Rebel, Gérard ^b  

^a CIBA GEIGY LTD   (Switzerland)

^b HÔPITAL CIVIL   (France)

Author keywords

Alkylating reagent; Ebselen; Histamine; Inflammation; Mast cells; N ethylmaleimide

Indexed keywords

COMPOUND 48-80; EBSELEN; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY;

ANIMAL CELL; ARTICLE; DOSE RESPONSE; HISTAMINE RELEASE; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, ANTI-IDIOTYPIC; AZOLES; HISTAMINE RELEASE; IMMUNOGLOBULIN E; KINETICS; MAST CELLS; ORGANOSELENIUM COMPOUNDS; P-METHOXY-N-METHYLPHENETHYLAMINE; PERITONEAL CAVITY; RATS;

EID: 0031794871     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00252-4     Document Type: Article

References (20)

1. Schewe T. Molecular actions of ebselen-an antiinflammatory antioxidant. Gen Pharmacol. 26:1995;1153-1169.
2. Parnham M.J., Graf E. Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions. Biochem Pharmacol. 36:1987;3095-3102.
3. Safayhi H., Tiegs G., Wendel A. A novel biologically active seleno-organic compound. V. inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase. Biochem Pharmacol. 34:1985;2691-2694.
4. Englberger W., Parnham M.J. Inhibition by ebselen of macrophage eicosanoid generation and lymphocyte proliferation in vitro. Br J Pharmacol. 87:1986;15P.
5. Parnham M.J., Kindt S. A novel biologically active seleno-organic compound. III. Effects of PZ 51 (ebselen) on glutathione peroxidase and secretory activities of mouse macrophages. Biochem Pharmacol. 33:1984;3247-3250.
6. Kuhl P., Borbe H.O., Fischer H., Römer A., Safayhi H. Ebselen reduces the formation of LTB4 in human and porcine leukocytes by isomerisation to its 5S, 12R-6-transisomer. Prostaglandins. 31:1986;1029-1048.
7. Hattori R., Inoue R., Eizawa H., Kasuga K., Aoyama T., Masayasu H., Kawai C., Sasayama S., Yui Y. Preferential inhibition of inducible nitric oxide synthase by ebselen. Eur J Pharmacol. 267:1994;R1-R2.
8. Barnes P.J., Chung K.F., Page C.P. Inflammatory mediators and asthma. Pharm Rev. 40:1988;49-84.
9. Mousli M., Trifilieff A., Pelton J.T., Gies J.P., Landry Y. Structural requirements for neuropeptide Y in mast cell and G-protein activation. Eur J Pharmacol. 289:1995;125-133.
10. Grosman N., Diamant B. The influence of phosphatidyl serine on the release of histamine from isolated rat mast cells induced by different agents. Agents Actions. 5:1975;296-301.
11. Shore P.A., Burkhalter A., Cohn V.H. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther. 127:1959;182-185.
12. Sies H. Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Radical Biol. 14:1993;313-323.
13. Müller A., Cadenas E., Graf P., Sies H. A novel biologically active seleno-organic compound. I. Glutathione peroxidase-like activity in vitro and anti-oxidant capacity of PZ 51 (ebselen). Biochem Pharmacol. 33:1984;3235-3239.
14. Noguchi N., Yochida Y., Kaneda H., Yamamoto Y., Niki E. Action of ebselen as an antioxidant against lipid peroxidation. Biochem Pharmacol. 44:1992;39-44.
15. Cotgreave I.A., Morgenstern R., Engman L., Ahokas J. Characterization and quantitation of a selenol intermediate in the reaction of ebselen with thiols. Chem Biol Interact. 84:1992;67-76.
16. Ishizaka T. Biochemical analysis of triggering signals induced by bridging of IgE receptors. Federation Proc. 14:1982;17-21.
17. 2+ release activities of inositol 1,4,5-triphosphate in the bovine adrenal cortex. Mol Endocrinol. 2:1988;1249-1255.
18. Supattapone S., Worley P.F., Baraban J.M., Snyder S.H. Solubilisation, purification and characterization of an inositol triphosphate receptor. J Biol Chem. 263:1988;1530-1534.
19. Dimmeler S., Brüne B., Ullrich V. Ebselen prevents inositol (1,4,5)-triphosphate binding to its receptor. Biochem Pharmacol. 42:1991;1151-1153.
20. Wargner G., Schuch G., Akerboom T.P.M., Sies H. Transport of ebselen in plasma and its transfer to binding sites in the hepatocyte. Biochem Pharmacol. 48:1994;1137-1144.